🔗 Shared analysis
All filings for Hawa Engineers Ltd →
Hawa Engineers Approves Un-Audited Financial Results for Quarter Ended June 30, 2026
Hawa Engineers Ltd has approved its un-audited financial results for the first quarter of FY27 (ended June 30, 2026). The board meeting was conducted on July 20, 2026, lasting 45 minutes. Given the company's small market capitalization of Rs 27 Cr and TTM revenue of Rs 114 Cr, these quarterly updates are significant for monitoring its thin net profit margins (TTM PAT of Rs 2 Cr). Investors should compare these results against the June 2025 revenue of Rs 24.52 Cr to assess year-on-year growth.
Confidence: HIGH
What changedThe company has officially approved and released its financial performance data for the April-June 2026 period.
Why it mattersFor a micro-cap industrial products company, quarterly results provide essential data on whether the company is managing its high debt (Rs 22 Cr) and maintaining its ROCE (16.0%) in a competitive sector.
TTM Revenue: Rs 114 CrMarket Cap: Rs 27 CrPrevious Q1 Revenue (Jun 2025): Rs 24.52 CrDebt-to-Equity Ratio: 0.96TTM PAT: Rs 2 Cr
📅 Short termThe stock price may react based on the specific revenue and margin trends revealed in the detailed Q1 filing compared to the previous year's performance.
📈 Long termLimited structural significance unless the results demonstrate a consistent expansion in operating margins beyond the current 5-6% range.
⚠ Risk flags
- High debt-to-equity ratio (0.96)
- Small market capitalization leading to potential liquidity risks
- Low net profit margins
Key Highlights
Board meeting held on July 20, 2026, to approve Q1 FY27 un-audited results
Meeting duration was 45 minutes, commencing at 4:15 PM and concluding at 5:00 PM
Company operates with a TTM revenue of Rs 114 Cr and a low OPM of 6.6%
Market capitalization remains small at approximately Rs 27 Cr
Debt-to-equity ratio stands at 0.96, with total debt of Rs 22 Cr against a net worth of Rs 23 Cr
👀 What to Watch
Investors should examine the detailed financial statement on the exchange website to check if the company has improved upon its previous Q1 (June 2025) net profit of Rs 0.48 Cr.
📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-10-16 15:16
152 analysed today
FollowTelegram
152
Today
151,596
All-time analysed
43,457
Positive
6,736
Negative
92,584
Neutral
8,751
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
1,000+ announcements match the current filters (relevance ≥ 5).
Ujjivan SFB to Raise ₹249.04 Cr via Preferential Equity Issue to IFC at ₹64.73/Share
Ujjivan Small Finance Bank has entered into a subscription agreement and policy agreement with existing shareholder International Finance Corporation (IFC). The bank plans to issue up to 3,84,73,561 equity shares at ₹64.73 each, aggregating to approximately ₹249.04 crore. IFC currently holds 6,21,32,650 shares (3.18% stake) in the bank. The fundraise represents approximately 2.0% of the bank's current market cap of ₹12,490 crore and will strengthen its Tier-1 capital base.
Confidence: HIGH
What changedUjjivan SFB formalized terms to issue fresh equity shares to IFC, raising ~₹249.04 crore and increasing IFC's ownership stake.
Why it mattersThe infusion bolsters the bank's capital adequacy to support loan book expansion, especially across its secured portfolio targets, while validating institutional confidence from a multilateral investor.
Total fundraise value: ~Rs. 249.04 CroresIssue price per share: Rs. 64.73Number of shares to be issued: Up to 3,84,73,561IFC pre-issue holding: 3.18%Fundraise vs Market Cap: ~2.0%
📅 Short termPositive sentiment from IFC expanding its commitment at ₹64.73, which is essentially at the current market price of ₹64.3.
📈 Long termStrengthens capital reserves and supports compliance with ESG and governance frameworks prescribed under IFC's policy agreement.
⚠ Risk flags
- Subject to shareholder and stock exchange in-principle approvals
- Minor equity dilution of existing shareholders
Key Highlights
Preferential issuance of up to 3,84,73,561 equity shares to IFC at an issue price of ₹64.73 per share
Total consideration to be raised aggregates up to ~₹249.04 Crores
IFC holds 6,21,32,650 equity shares (3.18% stake) as of October 15, 2026
Issuance is subject to shareholder approval and in-principle approval from BSE and NSE
👀 What to Watch
Track voting outcome on the shareholder resolution for the preferential issue along with stock exchange in-principle approval timelines.
MGEL Approves NCD Issuance Up to ₹150 Cr via Private Placement
Mangalam Global Enterprise Limited has approved the issuance of Senior, Secured, Rated, Listed Non-Convertible Debentures (NCDs) aggregating up to ₹150 crore on a private placement basis. The proposed debt fundraise is significant relative to MGEL's existing debt of ₹140 crore and net worth of ₹237 crore (representing ~63% of net worth and ~27% of its ₹554 crore market capitalization). The debentures are proposed to be listed on the NSE Debt Segment in one or more tranches. Specific terms, including coupon rate, tenure, and security creation, will be decided by the committee at subsequent approvals.
Confidence: HIGH
What changedManagement committee formally approved a debt fundraise framework of up to ₹150 crore via secured NCDs.
Why it mattersIf fully raised, MGEL's debt would more than double from ₹140 crore to nearly ₹290 crore, materially altering its D/E ratio from 0.59 to ~1.22.
Approved NCD issue size: Up to Rs. 150/- CroreIssue size vs Net Worth: ~63.3%Issue size vs Existing Debt: ~107.1%Issue size vs Market Cap: ~27.1%
📅 Short termMarket will focus on the pricing/coupon rate and investor participation once tranches are finalized.
📈 Long termGiven thin operating margins (1.9%), higher interest expenses could pressure profitability unless proceeds are deployed into higher-margin value-added castor oil operations.
⚠ Risk flags
- Material increase in leverage: debt could exceed net worth if fully drawn
- Key commercial terms (coupon, tenure) not yet disclosed
- Thin margin profile makes earnings sensitive to interest rate costs
Key Highlights
Board approved issuance of NCDs aggregating up to ₹150 Crore on a private placement basis
Securities will be Senior, Secured, Rated, Listed, taxable, redeemable, and transferable
Proposed for listing on the NSE Debt Segment in one or more series or tranches
Appointed MITCON Credentia Trusteeship Services Limited as the Debenture Trustee
Coupon rate, tenure, and asset charge details are yet to be determined by the committee
👀 What to Watch
Track subsequent filings for the final coupon rate, maturity tenure, end-use of proceeds (working capital vs capex), and the impact on borrowing costs given the low operating margin (~1.9%).
E2E Secures ₹1,000 Cr Sovereign AI Deal; Q2 FY27 Revenue Surges 411% to ₹223.8 Cr
E2E Networks reported massive growth in Q2 FY27, with operational revenue rising 410.8% YoY to ₹223.8 Cr and PAT turning around to ₹72.7 Cr from a loss of ₹13.5 Cr in Q2 FY26. The company also announced a binding term sheet worth ~₹1,000 Cr (excl. taxes) with an India-based Sovereign AI firm valid through June 2029 for NVIDIA Blackwell GPUs. Total live cloud GPUs reached ~5,100, including 1,024 NVIDIA B200s, driving EBITDA margin to 76.6%. The contract size of ~₹1,000 Cr represents over 320% of E2E's TTM revenue of ₹311 Cr.
Confidence: HIGH
What changedE2E reported a turnaround to substantial profitability in Q2 FY27 and secured a binding multi-year contract worth ~₹1,000 Cr for NVIDIA Blackwell GPUs.
Why it mattersThe multi-year contract provides multi-year revenue visibility and confirms strong commercial demand for newly deployed Blackwell GPUs, shifting models from pay-as-you-go to committed contracts.
Contract value: ~₹1,000 CrContract vs TTM revenue: ~321.5%Q2 FY27 Revenue: ₹2,238 MnQ2 FY27 EBITDA Margin: 76.6%Q2 FY27 PAT: ₹727 MnLive GPUs: ~5,100
📅 Short termStrong operational and financial momentum is evident as Blackwell deployments monetize rapidly, likely driving high market interest.
📈 Long termValidates E2E's positioning as India's sovereign AI cloud provider, locking in long-term utilization for expensive GPU infrastructure amidst rapid AI adoption.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Client concentration risk with large commitments tied to sovereign AI entities
- High capital intensity and hardware obsolescence risks associated with next-gen chip releases
- Rising borrowings, which expanded to ₹4,504 Mn on the balance sheet as of Sep-26
Key Highlights
Q2 FY27 revenue rose 410.8% YoY to ₹2,238 Mn (₹223.8 Cr) with EBITDA margin expanding to 76.6%
Binding term sheet signed for ~₹1,000 Cr through June 2029 for NVIDIA Blackwell GPUs (~321% of TTM revenue)
Q2 FY27 PAT surged to ₹727 Mn (₹72.7 Cr), up from a net loss of ₹135 Mn in Q2 FY26
Live GPU capacity expanded to ~5,100 units (including 1,024 NVIDIA B200s) with 1,024+ additional B200s planned
Monthly Revenue Run-rate (MRR) climbed to ₹751 Mn in September 2026, marking a 13.4x rise over 4 years
👀 What to Watch
Track execution and revenue conversion milestones of the ₹1,000 Cr sovereign contract, alongside delivery schedules of the planned 1,024+ additional B200 GPUs.
Mangalam Drugs Reports Rs 15.57 Cr Bank Loan Default Exceeding 30 Days
Mangalam Drugs and Organics disclosed continuing loan defaults exceeding 30 days on its cash credit accounts with Bank of Maharashtra and Bank of Baroda. The total overdue amount stands at Rs 15.57 Cr (Rs 1,557.27 Lacs) as of October 15, 2026. Defaults originated in October 2025 (October 17 for Bank of Maharashtra and October 20 for Bank of Baroda). This overdue amount equals approximately 31.8% of the company's Rs 49 Cr market capitalization, highlighting severe ongoing liquidity stress.
Confidence: HIGH
What changedFormal subsequent disclosure confirming ongoing default on revolving credit lines with two public sector banks lasting nearly a full year.
Why it mattersThe defaulted amount represents ~31.8% of market cap and ~14.8% of total debt (Rs 105 Cr), compounding pressure on a company already reporting TTM net losses of Rs -44 Cr.
Bank of Maharashtra Overdue: Rs 951.19 LacsBank of Baroda Overdue: Rs 606.08 LacsTotal Overdue Amount: Rs 15.57 CrTotal Overdue vs Market Cap: ~31.8%Total Overdue vs Debt (Rs 105 Cr): ~14.8%
📅 Short termNegative sentiment and elevated risk of formal recovery actions or asset freezes by Bank of Maharashtra and Bank of Baroda.
📈 Long termHeightened insolvency risk if credit lines remain frozen, which impairs raw material procurement and delays operational turnaround.
⚠ Risk flags
- Loan default / credit rating downgrade risk
- Severe liquidity crunch with TTM net loss of Rs -44 Cr
- Possible NCLT/SARFAESI recovery actions by lenders
Key Highlights
Total overdue amount of Rs 15.57 Cr across two lender cash credit facilities as of October 15, 2026
Overdue on Bank of Maharashtra Cash Credit account stands at Rs 951.19 Lacs, with default dating back to October 17, 2025
Overdue on Bank of Baroda Cash Credit account stands at Rs 606.08 Lacs, with default starting October 20, 2025
Company states it is making arrangements to pay overdue amounts as soon as possible
👀 What to Watch
Track lender actions regarding debt restructuring or potential recovery/NCLT proceedings, and monitor Q2 FY27 cash flows to assess working capital solvency.
Q2 Consolidated Revenue Up 18.2% YoY to ₹2,263.29 Cr; KMP Appointments Approved
Crompton Greaves Consumer Electricals reported consolidated revenue from operations of ₹2,263.29 crore for Q2 FY27 (quarter ended September 30, 2026), marking an 18.2% increase YoY from ₹1,915.57 crore in Q2 FY26. For the half-year ended September 30, 2026, consolidated revenue rose 14.9% YoY to ₹4,498.31 crore compared to ₹3,913.95 crore. The company also announced key leadership changes, appointing Aruna Arulsingh as Head - Legal, Company Secretary, and Compliance Officer, along with Dipalok Choudhary as Head - Internal Audit and Risk Assurance.
Confidence: HIGH
What changedApproved Q2 and H1 FY27 financial results and appointed new heads for Legal/CS and Internal Audit.
Why it mattersDemonstrates sustained top-line revenue recovery with 18.2% YoY growth relative to a TTM revenue base of ₹8,332 crore.
Q2 Consolidated Revenue: ₹2,263.29 crQ2 YoY Revenue Growth: 18.15%H1 Consolidated Revenue: ₹4,498.31 crH1 Standalone PBT: ₹337.11 cr
📅 Short termMarket sentiment should react positively to the 18.2% YoY top-line expansion, reflecting steady consumer demand across core appliances.
📈 Long termSustained revenue momentum supports execution under the Crompton 2.0 transformation strategy, although full-year margin expansion remains key.
⚠ Risk flags
- Standalone operating cash flow for H1 remained negative at ₹(165.39) crore due to working capital build-up
Key Highlights
Q2 consolidated revenue from operations reached ₹2,263.29 crore, up 18.2% YoY from ₹1,915.57 crore
Half-year consolidated revenue reached ₹4,498.31 crore versus ₹3,913.95 crore in the prior-year period
Standalone profit before tax for H1 stood at ₹337.11 crore compared to ₹261.98 crore in H1 FY26
Appointment of Aruna Arulsingh as Head - Legal & CS effective October 16, 2026, and Compliance Officer from October 17, 2026
👀 What to Watch
Track net profitability and segment margin progression in the detailed quarterly investor presentation, alongside updates on channel inventory ahead of the festive season.
Q2 FY27 Revenue 5.1x YoY to ₹223.8 Cr; Signs ₹1,000 Cr Sovereign AI Contract
E2E Networks reported strong Q2 FY27 results with revenue jumping 410.8% YoY (and 42.7% QoQ) to ₹2,238 Mn (₹223.8 Cr), driven by the deployment of NVIDIA Blackwell GPUs and improved fleet utilisation. Operating EBITDA margin expanded to 76.6% with PAT at ₹727 Mn (₹72.7 Cr), compared to a net loss of ₹185 Mn in the prior-year period. In addition to earnings, the company signed a multi-year binding term sheet of ~₹1,000 Cr valid through June 2029 with an Indian sovereign AI company, representing ~3.2x its TTM revenue (₹311 Cr). H1 FY27 PAT stood at ₹1,166 Mn versus a loss of ₹163 Mn in H1 FY26.
Confidence: HIGH
What changedE2E reported a massive scale-up in Q2 FY27 earnings and announced a binding ~₹1,000 Cr sovereign AI Blackwell cloud GPU contract extending through June 2029.
Why it mattersThe ~₹1,000 Cr order represents over 320% of TTM revenue (₹311 Cr), substantially de-risking fleet investments and confirming strong enterprise demand for its AI GPU infrastructure.
Q2 FY27 Revenue: ₹2,238 MnQ2 FY27 PAT: ₹727 MnContract Value: ~₹1,000 CrContract vs TTM Revenue: ~321.5%Q2 FY27 EBITDA Margin: 76.6%
📅 Short termThe sharp turnaround into strong profitability (PAT ₹72.7 Cr) and sequential growth (+42.7% QoQ) provides immediate financial validation for recent GPU capex cycles.
📈 Long termSecuring multi-year Sovereign AI commitments through 2029 establishes E2E as a critical domestic AI compute provider, supporting its target of high fleet utilisation alongside partner L&T.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Client concentration risk given the large size of the single sovereign AI contract
- High depreciation costs (₹740 Mn in Q2 alone) requiring consistently high fleet utilisation to maintain profitability
- Dependence on global chip supply chains and hyperscaler price competition
Key Highlights
Q2 FY27 Revenue grew 410.8% YoY and 42.7% QoQ to ₹2,238 Mn
EBITDA margin reached 76.6% with EBITDA at ₹1,715 Mn; PAT came in at ₹727 Mn
Signed a binding term sheet worth ~₹1,000 Cr with an Indian sovereign AI company through June 2029
September 2026 exit monthly run-rate revenue reached ₹751 Mn
H1 FY27 EBITDA reached ₹2,894 Mn, which is 2.3x the full-year FY26 EBITDA
👀 What to Watch
Track the conversion of the ₹1,000 Cr binding term sheet into cash flows, alongside capex delivery timelines and ongoing GPU utilisation metrics in upcoming quarters.
BLKASHYAP Wins ₹200.02 Cr Commercial Civil Works Order from Nourish Developers
B. L. Kashyap and Sons Limited has secured a domestic civil and structural works order worth ₹200.02 Crores (excluding GST) from Nourish Developers Private Limited. The contract pertains to Phase 3 civil structure works for a commercial building at One DXP, Sector 113, Gurugram, Haryana. The project is scheduled for completion within approximately 25 months. Relative to BLKASHYAP's TTM revenue of ₹1,388 Crores, this single contract represents approximately 14.4% of annual revenue, supporting order book replenishment.
Confidence: HIGH
What changedB. L. Kashyap has added a fresh ₹200.02 Crore civil and structural contract to its order pipeline.
Why it mattersThe order equals ~14.4% of TTM revenue (₹1,388 Cr) and ~31.3% of the company's market cap (₹639 Cr), strengthening forward revenue visibility in its core commercial building vertical.
Order value: ₹ 200.02 CroresExecution timeline: 25 months approx.Order vs TTM revenue: ~14.4%Order vs Market cap: ~31.3%
📅 Short termPositive sentiment driver for the stock as order accretion confirms ongoing commercial real estate demand in NCR (Gurugram).
📈 Long termProvides steady top-line revenue over the next 2+ years, though margin delivery will depend on raw material cost management given historical operating margins of ~7-8%.
⚠ Risk flags
- Execution delays or cost overruns over the 25-month timeline
- Private real estate client concentration risk
Key Highlights
Secured domestic commercial order worth ₹200.02 Crores (excluding GST)
Execution timeline is approximately 25 months
Client: Nourish Developers Private Limited for One DXP, Sector 113, Gurugram
Not a related party transaction; promoter has no interest in awarding entity
Letter of Acceptance (LOA) accepted on 16.10.2026
👀 What to Watch
Track quarterly order inflow trajectory and monitor revenue recognition milestone updates under the Percentage of Completion accounting method over the 25-month execution cycle.
Q2 FY27 Net Profit Rises 56.3% YoY to ₹21.63 Cr; Joint Venture Formed with TRL Krosaki
Raghav Productivity Enhancers Limited reported strong consolidated Q2 FY27 results with revenue from operations growing 46.0% YoY to ₹92.81 Cr compared to ₹63.59 Cr in Q2 FY26. Consolidated PAT for the quarter rose 56.3% YoY to ₹21.63 Cr from ₹13.84 Cr, translating to a basic EPS of ₹4.71. For H1 FY27, revenue reached ₹179.79 Cr while PAT stood at ₹41.21 Cr, tracking well against TTM revenue of ₹286 Cr. Additionally, the company disclosed the incorporation of a new joint venture, RPEL TRLK SILICATECH PRIVATE LIMITED, formed with TRL Krosaki Refractories on September 25, 2026.
Confidence: HIGH
What changedRPEL reported robust Q2 FY27 earnings with 46% top-line growth and formalized a joint venture arrangement with TRL Krosaki Refractories.
Why it mattersDemonstrates strong volumetric throughput and capacity utilization post FY25 expansion, while the TRL Krosaki JV may open further industrial refractory scale.
Q2 FY27 Revenue: ₹9,281.39 LakhsQ2 FY27 PAT: ₹2,163.44 LakhsH1 FY27 Revenue: ₹17,978.57 LakhsH1 FY27 PAT: ₹4,120.87 LakhsH1 Revenue vs TTM Revenue: ~62.9%
📅 Short termEarnings demonstrate operational momentum with sequential and annual margin expansion, likely providing fundamental support.
📈 Long termStrong execution from expanded 414,000 MTPA capacity and strategic alignment via the TRL Krosaki JV reinforce long-term competitive positioning.
⚠ Risk flags
- Receivables grew to ₹78.27 Cr from ₹58.22 Cr as of March 2026
- High market valuation (P/E > 130) leaves little room for earnings misses
Key Highlights
Q2 FY27 revenue from operations grew 46.0% YoY to ₹9,281.39 Lakhs (₹92.81 Cr) from ₹6,358.64 Lakhs
Consolidated net profit expanded 56.3% YoY to ₹2,163.44 Lakhs (₹21.63 Cr) vs ₹1,384.40 Lakhs in Q2 FY26
Diluted EPS for Q2 FY27 rose to ₹4.71 compared to ₹3.02 in the corresponding quarter last year
Formed a new JV entity 'RPEL TRLK SILICATECH PRIVATE LIMITED' with TRL Krosaki Refractories Limited on September 25, 2026
👀 What to Watch
Track the commercialization and capital commitment details of the new joint venture with TRL Krosaki, alongside sustained margin performance given the elevated valuation multiples.
Crompton Q2 FY27: Revenue Up 18.2% YoY, EBIT Margin Expands 70 bps to 7.0%
Crompton Greaves Consumer Electricals released its Q2 FY27 investor presentation, reporting an 18.2% YoY consolidated revenue growth, marking its third consecutive quarter of double-digit expansion. Consolidated EBIT margins expanded 70 bps YoY to 7.0%, while PBT margins increased 210 bps to 7.4%. Operating cash flows turned negative at -₹237.10 Cr for H1 FY27, driven by a ₹325.45 Cr increase in inventories to normalize supply chains. The company outlined its FY29 ambition targeting 13-14% revenue CAGR and 11-12% exit EBITDA margins.
Confidence: HIGH
What changedCrompton published its detailed Q2 FY27 investor presentation following board approval of financial results, detailing segment operational metrics and long-term FY29 milestones.
Why it mattersDemonstrates market share defense and double-digit top-line momentum across core and emerging categories despite raw material inflation and e-commerce channel adjustments.
Consolidated Q2 Revenue Growth (YoY): 18.2%EBIT Margin: 7.0%H1 FY27 Operating Cash Flow: -₹237.10 CrInventory Change in H1 FY27: -₹325.45 CrFY29 Exit EBITDA Margin Target: 11%-12%
📅 Short termSentiment is supported by robust 18.2% revenue growth and margin expansion, though working capital drag in H1 remains an operational watch point.
📈 Long termExpansion into high TAM categories (Solar Rooftop, Large Domestic Appliances) and premiumization under 'Crompton 2.0' target long-term double-digit compound growth.
⚠ Risk flags
- Commodity inflation putting persistent pressure on input costs
- Negative H1 operating cash flow of -₹237.10 Cr due to inventory absorption
Key Highlights
Consolidated revenue grew 18.2% YoY in Q2 FY27, accelerating from 11.8% in Q1 FY27
EBIT margin and PBT margin expanded by 70 bps to 7.0% and 210 bps to 7.4% respectively
Net cash used in operating activities stood at -₹237.10 Cr for H1 FY27 due to ₹325.45 Cr inventory buildup
FY29 targets reiterate 13-14% revenue CAGR and 11-12% exit EBITDA margins with ~₹120 Cr annual capex
👀 What to Watch
Track working capital unwinding and cash flow recovery in H2 FY27, along with gross margin trends against persistent commodity cost inflation.
SAL Steel Seeks Approval for Rs 1,050+ Cr Related Party Limits and Prior Loan Ratifications
S.A.L. Steel's Board approved a Postal Ballot notice to seek shareholder ratification and approval for substantial related-party transactions (RPTs) following its takeover by Sree Metaliks Limited (which holds a 57.51% equity stake). Key proposals include post-facto ratification of unsecured loans of Rs 228.67 Cr from Lawrence Merchants and Rs 174.62 Cr of raw material/loan facilities from Sree Metaliks. Additionally, the company is seeking 1-year omnibus approvals for up to Rs 1,050 Cr in transactions with Sree Metaliks (including Rs 500 Cr corporate guarantee and Rs 300 Cr raw material purchases) and Rs 200 Cr loan credit line from Lawrence Merchants. Remote e-voting runs from October 20 to November 18, 2026, with results due by November 20, 2026.
Confidence: HIGH
What changedThe Board approved dispatching a postal ballot notice to regularize historical related-party loans and establish large 1-year operational and financial omnibus limits with its new promoter group.
Why it mattersThe transactions are massive relative to the company's net worth of Rs 147 Cr, reflecting deep operational and balance sheet dependency on new holding entity Sree Metaliks and related lenders.
Lawrence Merchants Loan Ratification: Rs. 228.67 CroreSree Metaliks Facility Ratification: Rs. 174.62 CroreSree Metaliks Corporate Guarantee Limit: Up to Rs. 500 CrSree Metaliks Raw Material Purchase Limit: Up to Rs. 300 CrSree Metaliks Holding Stake: 57.51%Ratified Loans vs Net Worth (Rs 147 Cr): ~274%
📅 Short termShareholders will scrutinize the postal ballot disclosures and voting results ending mid-November 2026, particularly given the retrospective ratification of past borrowings.
📈 Long termOperationally, raw material sourcing arrangements with Sree Metaliks provide supply security for iron ore, but high financial guarantees and related-party financing tie company stability tightly to the promoter group.
⚠ Risk flags
- High volume of post-facto ratifications for material related-party borrowings
- Substantial related-party dependence with holding company Sree Metaliks across raw materials, loans, and guarantees
- Leverage remains elevated relative to net worth
Key Highlights
Post-facto ratification sought for Rs 228.67 Cr loan from Lawrence Merchants and Rs 174.62 Cr trade/loan cap from Sree Metaliks
Omnibus approval proposed for up to Rs 1,050 Cr in aggregate limits with parent Sree Metaliks, including Rs 500 Cr corporate guarantees
Credit line approval of up to Rs 200 Cr from Lawrence Merchants and Rs 150 Cr trade limits with Elite Metaliks
Disclosed that Sree Metaliks now controls a 57.51% equity stake in SAL Steel post-takeover
Remote e-voting scheduled from October 20, 2026, to November 18, 2026; results on or before November 20, 2026
👀 What to Watch
Monitor the outcome of the postal ballot voting concluding on November 18, 2026, and track if public shareholders approve the retrospective and future high-value related-party transactions.
Indo Rama Synthetics Approves ₹200 Cr Capex for Speciality Filament and Fibre
Indo Rama Synthetics' Board has approved an expansion capex of approximately ₹200 crore for the company and its wholly owned material subsidiary, Indorama Ventures Yarns Private Limited (IVYPL). The investment will be deployed at the Butibori plant in Nagpur, Maharashtra, to expand speciality filament and speciality fibre production. The estimated commercial operation date is within the next 12 to 18 months, funded via a mix of term loans and internal accruals. The capex represents approximately 35.5% of the company's net worth (₹564 crore) and about 4.4% of TTM revenue (₹4,541 crore).
Confidence: HIGH
What changedBoard approved an approx. ₹200 crore capex project for high-value speciality filament and fibre at the Butibori facility.
Why it mattersThe shift toward value-added speciality products could enhance operating profit margins above the current 7.1% TTM level, though it involves additional debt on an already leveraged balance sheet (D/E of 1.69).
Expansion Capex: approx. INR 200 CroresCapex vs Net Worth: ~35.5%Capex vs TTM Revenue: ~4.4%Implementation Timeline: next 12-18 months
📅 Short termPositive sentiment driver as the company targets higher-margin speciality segments, though capital outlay will be phased over coming quarters.
📈 Long termIf successfully commissioned within 12-18 months, speciality capacity can improve product mix and margin resilience against volatile commodity polyester cycles.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Execution delay risks over the 12-18 month horizon
- Balance sheet leverage risk: existing debt is ₹952 crore (D/E 1.69), and the capex will be partly debt-funded
Key Highlights
Board approved capex expansion of approx. INR 200 Crores across the company and wholly owned subsidiary IVYPL
Targeted towards speciality filament and speciality fibre production at the Butibori Plant in Nagpur, Maharashtra
Estimated commercial operation date (COD) scheduled within the next 12-18 months
Project will be funded via a combination of term loans and internal accruals
👀 What to Watch
Track the debt additions in upcoming quarterly balance sheets and monitor execution milestones toward the 12-18 month commercial operation timeline.
Venus Remedies Secures 5 Marketing Authorisations Across 4 International Markets
Venus Remedies has secured five marketing authorisations across Kazakhstan, Peru, Kuwait, and Argentina. The approved products include critical-care and oncology injectables: Vancomycin and Fluorouracil in Kazakhstan, Fulvestrant in Peru, Methotrexate in Kuwait, and Meropenem in Argentina. These approvals expand the company's existing footprint of over 100 countries across the CIS, Latin America, and Middle East regions. Commercial revenue potential and launch timelines were not disclosed.
Confidence: HIGH
What changedVenus Remedies received regulatory marketing authorisations for 5 injectable formulations across 4 countries (Kazakhstan, Peru, Kuwait, Argentina).
Why it mattersEnables commercial sales of critical care and oncology products in CIS, Latin American, and Middle Eastern markets, supporting international export growth.
Marketing authorisations secured: 5Target countries: 4Existing international footprint: over 100 countriesEstimated financial impact: not disclosed
📅 Short termPositive sentiment for export capabilities, though commercial revenue impact will take time to materialize.
📈 Long termExpands geographic diversification and deepens the penetration of Venus's high-margin injectable portfolio across emerging markets.
⚠ Risk flags
- Commercial uptake and pricing dynamics in target countries remain undisclosed
- Foreign exchange volatility risks on export realizations
Key Highlights
Secured 5 marketing authorisations across 4 international markets
Approvals span Kazakhstan (Vancomycin, Fluorouracil), Peru (Fulvestrant), Kuwait (Methotrexate), and Argentina (Meropenem)
Geographic scope covers CIS, Latin America, and Middle East regions
Adds to company's global footprint spanning over 100 countries
👀 What to Watch
Track the commercial rollout timeline and export revenue contribution from these registrations in upcoming quarterly results.
Q2 FY27 Net Profit Rises 139% YoY to ₹55.05 Cr; Standalone Revenue Up 7% to ₹1,248.33 Cr
Indo Rama Synthetics reported standalone revenue from operations of ₹1,248.33 Cr for Q2 FY27 (ended September 30, 2026), marking a 7.0% increase YoY compared to ₹1,166.29 Cr in Q2 FY26. Standalone net profit for the quarter rose sharply by 138.9% YoY to ₹55.05 Cr from ₹23.04 Cr. Operating cash flow improved significantly on a consolidated basis, generating ₹328.46 Cr for H1 FY27 compared to ₹91.46 Cr in H1 FY26, driven by working capital efficiencies. The company deployed this cash to pare down borrowings, reducing current borrowings by ₹206.98 Cr in H1.
Confidence: HIGH
What changedIndo Rama Synthetics reported its Q2 and H1 FY27 results, showing strong profit recovery and substantial operating cash generation used to pay down short-term debt.
Why it mattersHigher profitability and aggressive debt repayment strengthen the balance sheet of this high-debt manufacturer (D/E was 1.69), reducing finance costs which were ₹51.44 Cr standalone in H1.
Standalone Revenue (Q2 FY27): ₹1,248.33 crStandalone Net Profit (Q2 FY27): ₹55.05 crConsolidated CFO (H1 FY27): ₹328.46 crNet repayment of current borrowings (H1): ₹206.98 crQ2 Standalone Revenue vs TTM Revenue: ~27.5%
📅 Short termMarket response is likely to be supportive given the strong YoY earnings expansion and sharp turnaround in cash generation.
📈 Long termStructural improvement depends on sustained deleveraging and stabilizing margins against global commodity cycles in polyester and PTA.
⚠ Risk flags
- High sensitivity to raw material price fluctuations (crude oil and PTA)
- Substantial leverage despite recent repayments
Key Highlights
Standalone Q2 FY27 revenue grew 7.0% YoY to ₹1,248.33 Cr vs ₹1,166.29 Cr
Standalone Q2 FY27 net profit surged 138.9% YoY to ₹55.05 Cr from ₹23.04 Cr
Basic and diluted EPS for Q2 FY27 improved to ₹2.11 vs ₹0.88 in Q2 FY26
Consolidated H1 cash generated from operations grew to ₹328.46 Cr vs ₹91.46 Cr YoY
Net reduction in consolidated current borrowings stood at ₹206.98 Cr during H1 FY27
👀 What to Watch
Track whether margin expansion can be sustained amidst volatile crude/PTA input prices, and monitor continued debt reduction in the second half of FY27.
Q2 PAT Jumps 118% YoY to ₹229.81 Cr; Revenue Up 23% to ₹2,194.46 Cr
Jayaswal Neco Industries reported a strong performance for Q2 FY27 (ended September 30, 2026), with revenue from operations rising 23.2% YoY to ₹2,194.46 Cr compared to ₹1,781.00 Cr in Q2 FY26. Net profit surged 118.6% YoY to ₹229.81 Cr from ₹105.13 Cr, supported by significant savings in finance costs, which fell 45.2% YoY to ₹61.57 Cr following debt reduction. For H1 FY27, net profit stood at ₹423.73 Cr compared to ₹198.15 Cr in H1 FY26, with net cash from operating activities generating ₹968.17 Cr. Non-current borrowings reduced substantially to ₹739.53 Cr from ₹1,311.80 Cr as of March 31, 2026.
Confidence: HIGH
What changedJayaswal Neco reported its Q2 and H1 FY27 results showing substantial debt reduction and more than doubling of quarterly PAT YoY.
Why it mattersDeleveraging has slashed quarterly finance costs by over ₹50 Cr YoY, driving operational leverage directly into bottom-line expansion and balance sheet health.
Q2 Revenue from Operations: ₹2,194.46 CrQ2 Profit After Tax: ₹229.81 CrQ2 Finance Costs: ₹61.57 CrLong-term Borrowings reduction: ₹572.27 Cr reduction in H1H1 Operating Cash Flow: ₹968.17 Cr
📅 Short termEarnings show operational momentum and high earnings expansion, which could be received positively by the market.
📈 Long termSustained debt reduction significantly de-risks the capital structure and improves return ratios, aiding structural margin stability for the steelmaker.
⚠ Risk flags
- Pending revision petition at Delhi High Court regarding ED provisional attachment of ₹30,758 Lakhs (₹307.58 Cr)
- Cyclical vulnerability to steel prices and raw material price spikes
Key Highlights
Q2 revenue from operations grew 23.2% YoY to ₹2,194.46 Cr
Q2 net profit jumped 118.6% YoY to ₹229.81 Cr versus ₹105.13 Cr in Q2 FY26
Finance costs reduced sharply to ₹61.57 Cr in Q2 from ₹112.32 Cr in Q2 FY26
Non-current borrowings cut to ₹739.53 Cr as of Sep 30, 2026, down from ₹1,311.80 Cr as of Mar 31, 2026
Generated strong net operating cash flow of ₹968.17 Cr in H1 FY27
👀 What to Watch
Track whether debt repayment momentum and lower interest expenses sustain in the second half, alongside monitoring the Delhi High Court proceedings regarding the ED attachment order of ₹307.58 Cr.
Modison Q2 FY27 PAT Jumps 100% YoY to Rs 23.29 Cr; Declares Rs 4 Interim Dividend
Modison Limited reported a strong Q2 FY27 consolidated revenue of Rs 279.03 Cr, marking a 92.2% YoY growth compared to Rs 145.16 Cr in Q2 FY26. Consolidated PAT for the quarter doubled (+99.7% YoY) to Rs 23.29 Cr against Rs 11.66 Cr in the year-ago period, though sequential PAT softened 31.2% from Rs 33.84 Cr in Q1 FY27. For H1 FY27, net profit stood at Rs 57.13 Cr compared to Rs 16.47 Cr in H1 FY26. The Board also declared an interim dividend of Rs 4 per share (400% on face value Rs 1) with a record date of October 23, 2026.
Confidence: HIGH
What changedModison reported its Q2 and H1 FY27 results and declared an interim dividend of Rs 4 per share.
Why it mattersDemonstrates sustained top-line scale (>Rs 270 Cr quarterly run rate) compared to FY26 levels, reflecting market share gains in switchgear electrical contacts.
Q2 Consolidated Revenue: Rs 27,902.59 LakhsQ2 Consolidated PAT: Rs 2,328.89 LakhsInterim Dividend per share: Rs 4/-Record Date: October 23, 2026H1 FY27 Revenue vs TTM Revenue: ~65.0%
📅 Short termMarket sentiment should react positively to the 100% YoY profit expansion and healthy interim dividend payout ahead of the October 23 record date.
📈 Long termScale indicates strong industry demand across HV/LV switchgear segments; sustainability hinges on managing raw material inflation and customer concentration.
⚠ Risk flags
- High raw material dependence with raw materials consumed surging to Rs 266.64 Cr
- Sequential contraction in PAT from Rs 33.84 Cr in Q1 FY27 to Rs 23.29 Cr in Q2 FY27
Key Highlights
Q2 FY27 consolidated revenue up 92.2% YoY to Rs 279.03 Cr (vs Rs 145.16 Cr)
Consolidated PAT rose 99.7% YoY to Rs 23.29 Cr from Rs 11.66 Cr in Q2 FY26
H1 FY27 revenue reached Rs 549.49 Cr, up 96.7% YoY from Rs 279.30 Cr
Declared an interim dividend of Rs 4/- per share (400%) with record date October 23, 2026
Basic EPS for Q2 FY27 stood at Rs 7.18 per share vs Rs 3.59 YoY
👀 What to Watch
Track the upcoming Q3 FY27 operational performance and margin trajectory to observe if the elevated raw material costs (Rs 266.64 Cr consumed) compress operating margins.
Trident Lifeline Updates EGM Notice for Rs 41.14 Cr Preferential Issue Following BSE Queries
Trident Lifeline Limited has issued a corrigendum to its October 27, 2026 EGM notice after receiving observations from the BSE during its in-principle approval application. The proposed preferential issue entails offering up to 12,22,200 equity shares at an issue price of Rs 336.60 per share (including Rs 326.60 premium), aggregating to Rs 41.14 crore. The corrigendum rectifies Ultimate Beneficial Owner (UBO) details for proposed allottee Fincos Technology Solutions and incorporates regulatory disclosures under SEBI ICDR regulations. The fundraise represents approximately 11.3% of the company's current market capitalization of Rs 363 crore and 41.5% of net worth.
Confidence: HIGH
What changedThe company issued a corrigendum to update ICDR disclosures and rectify the Ultimate Beneficial Owner (UBO) information for an allottee pursuant to BSE queries.
Why it mattersEnsures regulatory compliance with BSE and SEBI ICDR regulations, paving the way for raising Rs 41.14 crore of fresh equity capital.
Total Issue Size: Rs 41,13,92,520Issue Price per Share: Rs 336.60Shares to be Offered: 12,22,200Issue Size vs Market Cap: ~11.3%Issue Size vs Net Worth: ~41.5%
📅 Short termProcedural compliance step that clarifies regulatory disclosures ahead of the shareholder vote scheduled for October 27, 2026.
📈 Long termIf approved and completed, the Rs 41.14 crore capital infusion will augment net worth and provide funding for ongoing expansion and product registrations across export markets.
⚠ Risk flags
- Equity dilution of existing shareholders upon issuance of 12,22,200 shares
- Regulatory approval risks subject to BSE clearing all disclosures
Key Highlights
Proposed preferential issue of up to 12,22,200 equity shares aggregating to Rs 41,13,92,520 (Rs 41.14 crore)
Issue price set at Rs 336.60 per share, which includes a face value of Rs 10 and a premium of Rs 326.60
EGM to seek shareholder approval scheduled for October 27, 2026 via video conferencing
Relevant date fixed as September 25, 2026 (30 days prior to the EGM date)
Corrigendum rectifies inadvertent errors in UBO disclosure for Fincos Technology Solutions Private Limited per BSE observations
👀 What to Watch
Track voting results of the EGM on October 27, 2026, and the subsequent receipt of final in-principle and listing approvals from BSE for the preferential allotment.
Capri Global Seeks Shareholder Nod for Up to ₹4,000 Cr Fundraise via Securities
Capri Global Capital Limited has issued a Postal Ballot Notice seeking shareholder approval via special resolution to raise up to ₹4,000 crore. The proposed fundraise represents approximately 16.7% of its current market cap (₹23,896 crore) and 59.4% of its net worth (₹6,736 crore). Capital may be raised in one or more tranches via equity shares, QIP, rights issue, ADR/GDR, FCCB, debentures, or other securities. The e-voting period runs from October 17, 2026, to November 15, 2026, with voting results to be declared on or before November 17, 2026.
Confidence: HIGH
What changedThe company has initiated an e-voting process to seek enabling shareholder approval to raise up to ₹4,000 crore in capital.
Why it mattersProvides headroom to raise substantial capital to support its target of growing AUM to ₹50,000 crore by FY28, though equity issuances could entail share dilution.
Proposed fundraise limit: ₹4,000 CroreFundraise vs Market Cap: ~16.7%Fundraise vs Net Worth: ~59.4%Cut-off date: October 09, 2026Voting end date: November 15, 2026
📅 Short termPrimarily procedural in the near term; market reaction will likely depend on the chosen mode of issuance (equity dilution vs debt) once approved.
📈 Long termIf successfully executed, the ₹4,000 crore capital base expansion will provide significant runway for lending growth across MSME, housing, and gold loans.
⚠ Risk flags
- Potential equity dilution risk if raised through QIP or equity-linked instruments
- Deployment risk in maintaining asset quality during rapid lending expansion
Key Highlights
Enabling resolution to raise funds up to ₹4,000 crore or equivalent in foreign currency
Proceeds intended for subsidiary investments, debt repayment, expansion plans, and working capital
Remote e-voting starts on October 17, 2026 (9:00 AM IST) and ends on November 15, 2026 (5:00 PM IST)
Record/Cut-off date for e-voting eligibility set as Friday, October 09, 2026
Results of the postal ballot to be declared on or before Tuesday, November 17, 2026
👀 What to Watch
Track the outcome of the postal ballot on November 17, 2026, followed by board decisions detailing the exact instrument, dilution level, and pricing.
Signs MoU with Omaxe to operate ~4,000 keys, expanding pipeline to ~16,000 keys
Lemon Tree Hotels, through its subsidiary Carnation Hotels, has signed a Memorandum of Understanding (MoU) with Omaxe Limited to operate approximately 4,000 keys across multiple destinations in India. This marks the company's largest single operating arrangement, boosting its total development pipeline to nearly 16,000 keys (compared to operational inventory of 10,956 rooms). The proposed sites cover transit hubs, pilgrimage centers, and commercial hubs including Lucknow, Vrindavan, Amritsar, and Greater Noida. The arrangement follows an asset-light management model, supporting Lemon Tree's high-margin management contract growth strategy.
Confidence: HIGH
What changedEntered an MoU with real estate developer Omaxe Limited to manage ~4,000 upcoming hotel keys across northern Indian markets.
Why it mattersAdds substantial asset-light capacity (+36.5% relative to current operational room inventory of 10,956), boosting high-margin management fee potential with zero direct capex.
Keys under MoU: ~4,000 keysKeys vs operational rooms: ~36.5%Total development pipeline post-MoU: nearly 16,000 keysNumber of locations: 8
📅 Short termPositive sentiment driver highlighting strong developer demand for Lemon Tree's brands, though immediate P&L impact will be minimal until properties open.
📈 Long termSignificantly strengthens Lemon Tree's asset-light footprint in high-growth Tier-2/3 pilgrimage and transit hubs, supporting long-term ROE and fee revenue expansion.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- MoU stage (non-binding risk before definitive contracts are finalized)
- Execution and construction delays typical of third-party real estate development
Key Highlights
Signs MoU with Omaxe to operate ~4,000 keys across Tier-2 and Tier-3 destinations
Company's largest single operating arrangement, taking total development pipeline to nearly 16,000 keys
Expansion covers 8 key locations including Lucknow, Vrindavan, Amausi, Amritsar, Ghaziabad, Greater Noida, Kaushambi, and Faridabad
Asset-light management model through wholly owned subsidiary Carnation Hotels Private Limited
👀 What to Watch
Track conversion from MoU into definitive operational management agreements and project completion milestones across the 8 identified locations.
Regency Fincorp Approves ₹312.15 Cr Fundraise via Shares and Warrants for Acquisitions
Regency Fincorp's board has approved a preferential fundraise of ₹312.15 crore, which is substantial compared to its current market cap of ₹366 crore. The issue consists of ₹72.05 crore via 1.43 crore equity shares and ₹240.11 crore via 4.75 crore convertible warrants, both priced at ₹50.50 per unit. Capital deployment plans include earmarking up to ₹120 crore for acquiring a digital lending platform, up to ₹75 crore for a gold loan business acquisition, and ₹32 crore for MSME onward lending. Following the phased fundraise, share capital is expected to increase to ₹152 crore, subject to shareholder and regulatory approvals.
Confidence: HIGH
What changedBoard approved raising ₹312.15 crore through preferential equity shares and convertible warrants to fund M&A and loan book expansion.
Why it mattersThe massive capital infusion nearly doubles the company's net worth (₹160 crore) and finances a major inorganic shift into gold loans and digital lending platforms.
Total fundraise: ₹312.15 croreFundraise vs Market Cap: ~85.3%Issue price per share/warrant: ₹50.50Allocation for digital lending acquisition: up to ~₹120 croreAllocation for gold loan acquisition: up to ~₹75 croreAllocation for MSME lending: ₹32 crore
📅 Short termStock may react to the pricing at ₹50.50 (a premium over the CMP of ₹45.60) and upcoming shareholder approval milestones.
📈 Long termIf successfully executed, the M&A deals and capital infusion will significantly scale up AUM, diversify the book into secured gold loans, and bolster net worth.
⚠ Risk flags
- Substantial equity dilution upon warrant conversion over the next 18 months
- M&A execution and integration risks for the proposed digital lending and gold loan acquisitions
- Subject to shareholder and regulatory approvals
Key Highlights
Board approved ₹312.15 crore preferential issue, representing ~85% of its ₹366 crore market cap
Issuance comprises 1,42,66,412 equity shares (~₹72.05 crore) and 4,75,46,030 convertible warrants (~₹240.11 crore) at ₹50.50 each
Up to ₹120 crore allocated for acquiring a digital lending platform within 1 year
Up to ₹75 crore allocated for acquiring a gold loan business within 6 months, plus ₹32 crore for MSME onward lending
Post-fundraise share capital is anticipated to rise to ₹152 crore in a phased manner
👀 What to Watch
Track upcoming shareholder voting on the preferential issue, regulatory clearances, and specific announcements regarding the target acquisition companies and their valuations.
Modison Q2 FY27 PAT Jumps 100% YoY to Rs 23.29 Cr; Declares Rs 4 Interim Dividend
Modison Limited reported a strong Q2 FY27 consolidated revenue of Rs 279.03 Cr, marking a 92.2% YoY growth compared to Rs 145.16 Cr in Q2 FY26. Consolidated PAT for the quarter doubled (+99.7% YoY) to Rs 23.29 Cr against Rs 11.66 Cr in the year-ago period, though sequential PAT softened 31.2% from Rs 33.84 Cr in Q1 FY27. For H1 FY27, net profit stood at Rs 57.13 Cr compared to Rs 16.47 Cr in H1 FY26. The Board also declared an interim dividend of Rs 4 per share (400% on face value Rs 1) with a record date of October 23, 2026.
Confidence: HIGH
What changedModison reported its Q2 and H1 FY27 results and declared an interim dividend of Rs 4 per share.
Why it mattersDemonstrates sustained top-line scale (>Rs 270 Cr quarterly run rate) compared to FY26 levels, reflecting market share gains in switchgear electrical contacts.
Q2 Consolidated Revenue: Rs 27,902.59 LakhsQ2 Consolidated PAT: Rs 2,328.89 LakhsInterim Dividend per share: Rs 4/-Record Date: October 23, 2026H1 FY27 Revenue vs TTM Revenue: ~65.0%
📅 Short termMarket sentiment should react positively to the 100% YoY profit expansion and healthy interim dividend payout ahead of the October 23 record date.
📈 Long termScale indicates strong industry demand across HV/LV switchgear segments; sustainability hinges on managing raw material inflation and customer concentration.
⚠ Risk flags
- High raw material dependence with raw materials consumed surging to Rs 266.64 Cr
- Sequential contraction in PAT from Rs 33.84 Cr in Q1 FY27 to Rs 23.29 Cr in Q2 FY27
Key Highlights
Q2 FY27 consolidated revenue up 92.2% YoY to Rs 279.03 Cr (vs Rs 145.16 Cr)
Consolidated PAT rose 99.7% YoY to Rs 23.29 Cr from Rs 11.66 Cr in Q2 FY26
H1 FY27 revenue reached Rs 549.49 Cr, up 96.7% YoY from Rs 279.30 Cr
Declared an interim dividend of Rs 4/- per share (400%) with record date October 23, 2026
Basic EPS for Q2 FY27 stood at Rs 7.18 per share vs Rs 3.59 YoY
👀 What to Watch
Track the upcoming Q3 FY27 operational performance and margin trajectory to observe if the elevated raw material costs (Rs 266.64 Cr consumed) compress operating margins.
